Flavia Pease and Timothy Stonesifer to join Board of Directors Shacey Petrovic and Corinne Nevinny to retire from the Board at the Company’s 2024 Annual Meeting -Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump…
Kindeva Drug Delivery (“Kindeva”), a global leader in drug and device combination products, today announced the acquisition of Summit Biosciences Inc. ( “Summit”), an intranasal drug development and manufacturing organization (CDMO), with its founding family shareholders. Established in 2009, Summit has a long history…
Noom’s Partnership with FitOn Addresses Negative GLP-1 Side Effects Head On the leading digital healthcare company empowering people to live better, healthier lives, is proud to announce a partnership with FitOn to add a “Muscle Defense” enhancement to its newly…
Medical Device Leaders to Gather at DeviceTalks Boston on May 1-2 DeviceTalks, a leading multimedia content and event provider for medical device professionals, proudly announces the return of its annual DeviceTalks Boston conference to the Boston Convention & Exhibition Center on May…
By Taking an AI-Powered Approach to Combat Malnutrition, Hologram Sciences Strengthens Precision Nutrition Platform At the 54th World Economic Forum, Hologram Sciences , an AI-driven health technology company, outlines its commitment to addressing historic healthcare challenges, particularly the malnutrition of patients. The company’s…
Devonian Health Group Inc. (“ Devonian ” or the “ Company ”) ( TSXV: GSD; OTCQB: DVHGF ), a late-stage botanical biopharmaceutical company focused on the development of a unique portfolio of prescription drugs and cosmeceutical products of botanical origin, is pleased to announce that as…
a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announces that it has received approval of its application to initiate a Phase 1/2 clinical trial (CTA) with SENS-501…
Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, and Hackensack Meridian Health (“HMH”), a leading not-for-profit health care organization and the largest, most comprehensive and truly integrated network in New…
CareALERTS closes healthcare gaps including raising immunizations rates among seniors and adults On National Pharmacist Day, XiFin celebrates pharmacists and urges all U.S. states to recognize pharmacists as providers OmniSYS, the pharmacy division of XiFin, Inc., announced its 2023 end-of-year…
The “Portable Ultrasound Equipment – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. Global Portable Ultrasound Equipment Market to Reach $2.9 Billion by 2030 The global market for Portable Ultrasound Equipment estimated at US$1.8 Billion in the year 2022, is projected…
Extensive prior art renders Exact Sciences’ patent relating to stool collection and processing invalid Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced that it has petitioned the United States…
KEYTRUDA is the first and only anti-PD-1 therapy approved in combination with chemoradiotherapy for these patients Approval marks third FDA-approved indication for KEYTRUDA in cervical cancer and 39th indication for KEYTRUDA in the US Merck (NYSE: MRK), known as MSD outside…